Circulating Th9/IL-9 levels were increased in patients with acute coronary syndrome (ACS) and in atherosclerotic mice, whereas recombinant mouse IL-9 treatment aggravated the development of atherosclerosis in high-fat diet-fed ApoE-/- mice. Here, IL9 is linked to acute coronary syndrome.